ClinicalTrials.gg
Not yet recruitingNCT07938372Updated Nov 16, 2026

Effect of Guided Imagery on Anxiety, Depression, and Fatigue in Patients Receiving Hemodialysis

An interventional study of Guided imagery in Hemodialysis, Anxiety and Depression, sponsored by Adiyaman University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Adiyaman University · Not applicable, Interventional, and Supportive care

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate whether a four week guided imagery program, delivered three times per week before hemodialysis, affects anxiety, depression, and fatigue in adults receiving hemodialysis compared with routine care. Measures are planned before the intervention and at the end of week four.

Read the detailed description

This study evaluates guided imagery as a supportive nursing intervention for adults receiving hemodialysis. It focuses on anxiety, depression, and fatigue during a four-week intervention period.

02

Conditions studied

  • Hemodialysis
  • Anxiety
  • Depression
  • Fatigue
  • Guided Imagery Exercise
  • Randomized Controlled Trial

Browse trials for

Keywords

  • Guided imagery
  • hemodialysis
  • anxiety
  • depression
  • fatigue
03

In context

Depression Reclassified

8,595 studies on the registry are indexed under Depression; 1,728 are open to participants now.

This study's planned enrollment of 90 is above the median of 81 across 7,074 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Adiyaman University is the lead sponsor of 32 studies on the registry; 12 are open to participants now.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

  • Aged 18 years or older
  • No cognitive impairment or history of psychiatric illness
  • Willing and able to communicate
  • Receiving hemodialysis for more than six months
  • No hearing, visual, or speech impairment
  • Voluntary agreement to participate in the study Exclusion Criteria
  • Not receiving regular hemodialysis treatment (dialysis instability)
  • Unwilling to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    Control group

    Participants in this group will receive routine hemodialysis care without the guided imagery intervention during the four-week study period.

  • Experimental
    Guided imagery group

    Guided imagery: Patients will undergo guided imagery three times a week for four weeks. Thirty minutes before hemodialysis, patients will be asked to assume a comfortable position, close their eyes, and take deep breaths. Depending on their preference, various nature sounds such as ocean waves, chirping forest birds, or falling rain will be played through over-ear headphones. Patients will then be asked to imagine themselves in the location depicted in the sound recording, using their senses of sight, hearing, smell, and touch.

    Other: Guided imagery

Interventions

  • OtherGuided imagery

    Participants will listen to nature sounds through headphones and be guided to imagine the scenes described by the audio, engaging their senses. The intervention will be delivered three times per week for four weeks, 30 minutes before hemodialysis.

06

What researchers measure

Primary outcomes

  1. anxiety

    Hospital Anxiety-Depression Scale

    Time frame: Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2 HADS : 0 to 21 scores, higher scores indicate worse outcomes. PFS: 0 to 230 scores, higher scores indicate worse outcomes.

  2. depression

    Hospital Anxiety-Depression Scale

    Time frame: Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2 HADS : 0 to 21 scores, higher scores indicate worse outcomes. PFS: 0 to 230 scores, higher scores indicate worse outcomes.

Secondary outcomes

  1. fatigue

    Piper Fatigue Scale

    Time frame: Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2 HADS : 0 to 21 scores, higher scores indicate worse outcomes. PFS: 0 to 230 scores, higher scores indicate worse outcomes.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Beizaee Y, Rejeh N, Heravi-Karimooi M, Tadrisi SD, Griffiths P, Vaismoradi M. The effect of guided imagery on anxiety, depression and vital signs in patients on hemodialysis. Complement Ther Clin Pract. 2018 Nov;33:184-190. doi: 10.1016/j.ctcp.2018.10.008. Epub 2018 Oct 17. PubMed 30396619 ↗
  • Bossola M, Hedayati SS, Brys ADH, Gregg LP. Fatigue in Patients Receiving Maintenance Hemodialysis: A Review. Am J Kidney Dis. 2023 Oct;82(4):464-480. doi: 10.1053/j.ajkd.2023.02.008. Epub 2023 May 13. PubMed 37187283 ↗
  • Afshar M, Mohsenzadeh A, Gilasi H, Sadeghi-Gandomani H. The effects of guided imagery on state and trait anxiety and sleep quality among patients receiving hemodialysis: A randomized controlled trial. Complement Ther Med. 2018 Oct;40:37-41. doi: 10.1016/j.ctim.2018.07.006. Epub 2018 Jul 11. PubMed 30219466 ↗

Individual participant data

Plan to share: No — It can be provided upon request from researchers.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.

Of 3,476 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 4 months is below that.

Counting every sponsor, half of 3,574 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 25, 2026
First posted
Nov 16, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Mar 1, 2027
CompletionEst.
May 15, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938372
Lead sponsor
Adiyaman University
Responsible party
Reva Gündoğan (Assistant Professor, Adiyaman University) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Mar 1, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Reva GÜNDOĞAN, Assistant Professor
Contact
r4a5reva@gmail.com
+905551822097
Sevim Güler, nurse PhD
Contact
sdegerguler@gmail.com
+905055894983

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion